Skip to content
Home/Companies/Pharma/Lomapharm
Lomapharm

Lomapharm

Pharma·Germany·Exited 2018·Held 5yr
Entry
2013
Hold
5yr
Exit
2018

Who owns Lomapharm?

Lomapharm was owned by DUBAG Group through Lenbach Equity Opportunities I (2017 vintage) from 2013 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

DUBAG Group
Investor
DUBAG Group
Lenbach Equity Opportunities I · 2017 · Evergreen

Key facts

HQGermany
SectorPharma
StatusAcquired
Websitelomapharm.de
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Lenbach Equity Opportunities I

Other portfolio companies in the same fund.

Scheven
Scheven
Exited 2020
IndustrialsGermany· 2017
to
Schwinn
Schwinn
Exited 2020
ConsumerGermany· 2015
to
epsotech
epsotech
Active
IndustrialsGermany· 2014
MMC Studios
MMC Studios
Exited 2019
TMTGermany· 2013
to
IDC (International Detergent Compounds)
Exited 2012
IndustrialsGermany· 2010
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Lomapharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Lomapharm?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Lomapharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue